The largest database of trusted experimental protocols

120 leaf millennium multileaf collimator mlc

Manufactured by Agilent Technologies

The 120 leaf Millennium Multileaf Collimator (MLC) is a medical device designed for use in radiation therapy. It serves as a component that shapes the radiation beam to conform to the shape of the target area during treatment.

Automatically generated - may contain errors

2 protocols using 120 leaf millennium multileaf collimator mlc

1

Comparative Evaluation of Advanced Radiotherapy Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hybrid IMRT/VMAT, IMRT, and VMAT plans were designed for each patient. The prescribed dose to the PTV was 66 Gy in 33 fractions. The plans were normalized to cover 95% of the PTV with 100% of the prescribed dose. The optimization objectives and constraints shown in Table 1 were the same for the three techniques. Eclipse 10.0 (Varian, Palo Alto, CA) treatment planning system was used for all treatment planning, utilizing 6 MV photon beams generated from Varian Trilogy linac equipped with a 120 leaf Millennium Multileaf Collimator (MLC).
+ Open protocol
+ Expand
2

Multimodal Radiation Therapy Planning

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hybrid IMRT/VMAT, IMRT, and VMAT plans were designed for each patient. Dose prescription included 70 Gy to PTV70, 59.4 Gy to PTV59.4, and 54 Gy to PTV54 with the plan normalization to cover 95% of the PTV54 with 100% of the prescribed dose. Eclipse 10.0 (Varian, Palo Alto, CA) treatment planning system was used for treatment planning, utilizing 6 MV photon beams generated from Varian Trilogy linac equipped with a 120-leaf Millennium Multileaf Collimator (MLC).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!